SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is currently trending as members of the 'SHIB Army' rally to maintain momentum, with active discussions focusing on token burn mechanisms, comparisons to other meme coins, and potential long-term price appreciation. Community sentiment remains polarized between long-term bulls anticipating a massive breakout and skeptics who view the asset as a speculative gamble with a high circulating supply.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin shares are experiencing heightened volatility ahead of crucial Supreme Court oral arguments and upcoming earnings, as the community remains divided between extreme pessimism over past litigation failures and speculative optimism surrounding a rumored new drug formulation and potential buyout. While long-term shareholders express deep frustration over multi-year share price stagnation and a lack of transparency, others are intensely focused on whether a legal remand could finally clear the path for a strategic transaction.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as investors show renewed interest in its role as a leading real-world asset (RWA) project, with the community actively debating the token's governance structure versus its potential for future fee-based revenue. Market participants are closely watching for legislative developments like the Clarity Act and potential DAO governance votes, which many believe could serve as the next major catalysts for the asset's long-term adoption.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is facing significant short-term bearish pressure and volatility as investors pivot away from high-valuation growth stocks, leading the community to debate whether current prices represent a generational buying opportunity or a deeper correction. While some investors remain fixated on the long-term potential of trapped-ion technology and the company's expanding manufacturing ecosystem, others are closely tracking the SkyWater merger progress and potential government contract catalysts that could stabilize the stock.

e.l.f. Beauty, Inc. is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, naturium, well people, and keys soulcare. The company was founded in 2004 and is headquartered in Oakland, CA.

e.l.f. Beauty Inc

e.l.f. Beauty is trending as investors debate its potential for a sharp rebound from recent lows, with many in the community viewing the current price as a generational buying opportunity. Traders are closely monitoring the stock for signs of a technical breakout and rotational capital inflows, while others highlight strong consumer brand loyalty and the Rhode acquisition as key long-term catalysts.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors aggressively position themselves ahead of an anticipated Phase 3 IZAR-1 clinical trial readout, which the community widely expects to drop this weekend. Speculation centers on the potential for best-in-class efficacy data to catalyze a major rerating of the stock, with community discourse heavily focused on the drug's competitive positioning, the probability of a multi-billion dollar acquisition, and high-stakes options activity.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is currently a focal point for institutional investors and short sellers, driven by the recent return of founder Thomas Siebel as CEO and a significant cash injection that has sparked debate over the firm's turnaround potential. The community is actively discussing the stock's high short interest and institutional accumulation, weighing these bullish signals against concerns regarding historical revenue volatility and intense competition within the enterprise AI sector.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras Systems is capturing significant market attention as it cements its position in the AI inference landscape through high-profile partnerships with AMD and CrowdStrike, showcasing the performance advantages of its wafer-scale architecture. The community remains intensely focused on the stock's high volatility and potential for long-term growth, with active debates centered on its valuation, leadership strategy, and its ability to compete in a crowded AI hardware ecosystem.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently facing significant downward pressure as investors rotate out of defensive stocks and react to persistent concerns over consumer spending and menu pricing. While some traders are attempting to play the stock for a potential value-based rebound, the community remains divided, with bearish voices citing a weakening technical outlook while others highlight its long-term dividend reliability.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is currently trending as the community debates its price action in response to volatile tech sector shifts and broad market reactions to cooling economic data. Traders are actively discussing swing strategies, leveraging the ETF's volatility to capitalize on recent dips while weighing the impact of hyperscaler AI spending on the broader semiconductor landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Oruka Therapeutics Inc.

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

ABIOARCA biopharma Inc

Fundamentals

Latest ABIO News